Open Access

[Corrigendum] lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling

  • Authors:
    • Ting Tang
    • Ling-Xing Wang
    • Mei-Li Yang
    • Rong-Mou Zhang
  • View Affiliations

  • Published online on: July 1, 2025     https://doi.org/10.3892/mmr.2025.13605
  • Article Number: 240
  • Copyright : © Tang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

September-2025
Volume 32 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tang T, Wang L, Yang M and Zhang R: [Corrigendum] lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling. Mol Med Rep 32: 240, 2025.
APA
Tang, T., Wang, L., Yang, M., & Zhang, R. (2025). [Corrigendum] lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling. Molecular Medicine Reports, 32, 240. https://doi.org/10.3892/mmr.2025.13605
MLA
Tang, T., Wang, L., Yang, M., Zhang, R."[Corrigendum] lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling". Molecular Medicine Reports 32.3 (2025): 240.
Chicago
Tang, T., Wang, L., Yang, M., Zhang, R."[Corrigendum] lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling". Molecular Medicine Reports 32, no. 3 (2025): 240. https://doi.org/10.3892/mmr.2025.13605